Share this @internewscast.com
Concerns over the accuracy of melatonin product labeling have been heightened following a discovery that one product contained a staggering 400 percent more melatonin than advertised. This discrepancy poses a risk of accidental overdose for unsuspecting consumers.
In a surprising twist, another product was found to contain no detectable melatonin at all, raising questions about the reliability of these supplements. Furthermore, at least four other products were identified to have significantly less melatonin than indicated on their labels.
In response, the Therapeutic Goods Administration (TGA) has taken action. They have informed the Australian Border Force (ABF) to intercept and destroy any counterfeit melatonin products found at the border. The TGA’s vigilance extends beyond this, as they consistently monitor for harmful and unregistered products within Australia.
- Life Extension Melatonin 300mcg Vegetarian capsules – 79 per cent to 97 per cent less
- Sleepose-10 Melatonin 10mg tablets – 37 per cent to 59 per cent less
- Live Nature’s Melatonin 10mg capsules – no melatonin detected
- Sanofi Novanuit Triple Action 1mg Melatonin + plant extracts tablets – 76 per cent to 99 per cent less
Consumers who currently possess any unregistered melatonin products are strongly advised by the TGA to cease their use immediately, prioritizing their health and safety over uncertain benefits.
It also constantly monitors for harmful unregistered products in Australia.
The TGA has urged any consumers in possession of unregistered melatonin products to stop taking them immediately.
Any remaining products can be taken to a local pharmacy for safe disposal.
Anyone with concerns about having used unregistered or counterfeit melatonin products should speak to a medical professional and report any adverse side effects to the TGA.
The TGA cautions Australians against buying any medicines from unknown overseas websites.
NEVER MISS A STORY: Get your breaking news and exclusive stories first by following us across all platforms.